Universal Integrated

Company snapshot

Universal Integrated maintains 89 tracked programs across Rheumatoid Arthritis, Calcium, Polycystic Ovary Syndrome, Diabetic Foot, Plaque Psoriasis, Hepatitis C, Chronic, Psoriasis Vulgaris, Acute Ischemic Stroke, Bowel Preparation, Brain Infarct, ICSI, Breast Cancer. Momentum score: 20/100 (30-day delta: n/a). Public registry data covers pipeline phase, clinical trials, patents, SEC filings, and

• 89 active pipeline program(s) linked via ClinicalTrials.gov.
• 42 US patent(s) indexed to this assignee profile.
• 89 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Universal Integrated. Not investment advice.

• Peer + 0 momentum

  HOFFMANN-LA ROCHE

  TA overlap score 50

• Peer + 0 momentum

  Vertex Pharmaceuticals (Australia)

  TA overlap score 40

• Peer + 0 momentum

  Chinese Academy of

  TA overlap score 40

• Peer + 0 momentum

  First People's Hospital

  TA overlap score 40

• Peer + 0 momentum

  Coherus Oncology

  TA overlap score 25

• Peer + 0 momentum

  Can Fite Biopharma

  TA overlap score 24

• Peer + 0 momentum

  Provectus Biopharmaceuticals

  TA overlap score 22.4

• Peer + 0 momentum

  Artiva Biotherapeutics

  TA overlap score 21.6

Recent activity

Latest pipeline, patent, and corporate events for Universal Integrated.

1. Jun 8, 2026 Clinical update

   Z171100001017104 — Phase 2

2. Jun 8, 2026 Clinical update

   UIC-STP-2017 — Phase 3

3. Jun 8, 2026 Clinical update

   UIC-BKL-2013 — Phase 3

4. Jun 8, 2026 Clinical update

   Xingnaojing injection — Approved

5. Jun 8, 2026 Clinical update

   Triamcinolone Acetonide Acetate and Urea Cream. — Phase 2

View all clinical trial activity →

• What is Universal Integrated?

  Universal Corporation is a pharma organization headquartered in HILLSIDE, NJ, CN. Primary therapeutic focus areas include Rheumatoid Arthritis, Calcium, Polycystic Ovary Syndrome, Diabetic Foot, Plaque Psoriasis. NovaPharmaNews links 89 clinical program(s), 0 drug profile(s), and

• Is Universal Integrated publicly traded?

  Universal Integrated appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Universal Integrated develop or market?

  We link 105 drug profile(s) where Universal Integrated is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/integrated-biopharma-inc#company-drugs.

• What are the latest developments for Universal Integrated?

  In the last 12 months our linked public records show 89 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Universal Integrated focus on?

  Universal Integrated focuses on Rheumatoid Arthritis, Calcium, Polycystic Ovary Syndrome based on our analysis of their pipeline programs and drug development activities.